To include your compound in the COVID-19 Resource Center, submit it here.

SA3Ag vaccine: Phase I data

A double-blind, placebo-controlled Phase I trial in 408 healthy volunteers showed that

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE